Overview of Lung Transplantation, Heart-Lung Transplantation, Liver-Lung Transplantation, and Combined Hematopoietic Stem Cell Transplantation and Lung Transplantation
Lung transplantation (LTx) has evolved to represent the therapy of choice for many patients with end-stage lung diseases. Appropriate candidate selection for LTx is an important determinant of a positive outcome from transplantation. Posttransplantation survival has steadily improved, but long-term survival continues to be a challenge with a median survival of 5.8 years. Similarly, combined heart-lung transplantation and simultaneous liver-lung transplantation has been performed successfully in select patients who are not expected to survive either organ transplant alone. Moreover, LTx has been performed in patients who develop end-stage pulmonary complications following hematopoietic stem cell transplantation.
Source: Clinics in Chest Medicine - Category: Respiratory Medicine Authors: Shruti Gadre, Jason Turowski, Marie Budev Source Type: research
More News: Cardiology | Heart | Heart Transplant | Liver | Liver Transplant | Lung Transplant | Respiratory Medicine | Stem Cell Therapy | Stem Cells | Transplant Surgery | Transplants | Urology & Nephrology